video corpo

cobas b 101 system - 6 Pages

Add to MyMedicalExpo favorites
cobas b 101 system

Catalog excerpts

cobas b 101 system Enhancing patient care at the point of need with combined HbA1c and lipid panel testing COBAS, COBAS B and LIFE NEEDS ANSWERS are trademarks of Roche. ©2013 Roche Roche Diagnostics International Ltd CH-6343 Rotkreuz Switzerland www.cobas.com

 Open the catalog to page 1

Diabetes and dyslipidemia Two growing global health issues that significantly i ­ ncrease the risk of cardiovascular disease (CVD) Both diabetes and dyslipidemia are growing in prevalence every year, yet only 50 % of people who have either disease are diagnosed.1,2 A challenge to global healthcare By 2012 the number of people living with diabetes reached 371 million worldwide.1 In this year alone 4.8 million people died as a result of having the disease.1 If left untreated, increased blood glucose levels may lead to serious complications affecting the heart and blood vessels, eyes, kidneys,...

 Open the catalog to page 2

Metabolic syndrome Driving a new global CVD epidemic Metabolic syndrome identifies those at high risk of developing CVD and diabetes Most individuals with CVD have multiple risk factors, of which several are interrelated and cluster together.13,14 The presence of multiple risk factors adds substantial CVD risk over and above the sum of the risk associated with each individual risk factor.13 Around 20 – 25 % of the world’s adults have metabolic syndrome, a term used to describe a group of such risk factors (Fig. 1).13 People with metabolic syndrome have a three-fold higher risk of heart...

 Open the catalog to page 3

Point-of-care testing … has the potential to improve monitoring of chronic conditions, therapeutic control and clinical efficiency, and to enhance clinical decision making within the timeframe of the consultation.17 Immediate feedback of HbA1c results using a pointof-care device can improve patients’ glycemic control Usual care testing Absolute change in HbA1c (%) Optimising management of patients with diabetes at the physician’s office Immediate feedback of HbA1c results can improve patients’ glycemic control (Fig. 2) and increase the percentage of patients within their HbA1c target...

 Open the catalog to page 4

cobas b 101 system Enhancing patient care at the point of need with combined HbA1c and lipid panel testing The cobas b 101 system is a point-of-care device offering combined HbA1c and lipid panel* testing on one platform. From patient preparation to the display of HbA1c test and lipid panel results in one 15-minute workflow 1 The cobas b 101 system can support physicians to optimise the management of patients with diabetes and dyslipidemia, and support the early diagnosis of patients with metabolic syndrome who are at high risk of developing CVD and diabetes. The cobas b 101 system offers...

 Open the catalog to page 5

Easy and safe handling of samples and test discs • Direct sample application from a single finger prick and no capillaries, tubes or pipettes are needed for sample collection • Requires only very small sample volumes (2 μL for HbA1c, 19 μL for lipids) with self-filling discs • Discs can be stored for more than 13 months from production at room temperature (2 – 30 ºC) Comprehensive connectivity and data management • IT connectivity solutions are available with the cobas IT 1000 application • cobas b 101 supports POCT1A interface protocol and can be connected to Data Management Systems,...

 Open the catalog to page 6

Archived catalogs

  1. Roche in Brief

    32 Pages

  2. Roche in Brief

    32 Pages